LONDON, 6 October 2021: Arix Bioscience plc (“Arix” or the “Company”) (LSE: ARIX), a global venture capital company focused on investing in and building breakthrough biotech companies, today announces the following updates to its Board and Executive team: Following six months as interim CEO, Robert Lyne has been appointed permanent Chief Executive Officer, effective immediately. Sir […]
Industry veteran with decades of experience in company formation, scientific research, and drug development to join executive leadership team to accelerate pipeline potential BOSTON and LONDON, Oct. 05, 2021 (GLOBE NEWSWIRE) — Centessa Pharmaceuticals plc (“Company”) (Nasdaq: CNTA), a clinical-stage company leveraging its innovative asset-centric business model to discover, develop and ultimately deliver impactful medicines […]
The Hague, Netherlands, 5 October 2021: Amber Implants, an innovative medical technology company developing next generation spinal implants for spinal injuries, today announces its VCFix® spinal system, which aims to improve the treatment of vertebral fractures, has been granted the Breakthrough Device Designation by the US FDA. Read more…
DelSiTech Awarded UnitaidExplore Funding for Innovations in Paediatric Healthcare For development of novel delivery strategies for children’s medicines Turku, Finland – 4 October 2021: DelSiTech Ltd, the leader in silica based drug delivery technologies with its headquarters in Turku, Finland, and Unitaid, a global health initiative hosted by the World Health Organisation, announce the awarding of […]
Torsten Mummenbrauer, Chief Executive Officer of ExeVir will be speaking on a panel discussion titled “Advances in Covid Therapeutics” taking place at 11.00 CET on Wednesday 6th October 2021 and chaired by Max Herrmann, Managing Director, Stifel Financial Corp. Read more…
